These results indicate that Cirsiliol alleviates cardiac damage in DCM through multiple pathways: by reducing MDA levels, restoring SOD activity to alleviate oxidative stress, inhibiting Bax-mediated apoptosis, and downregulating the expression of IL-6/TNF-α to relieve inflammation. This evidence concerns the gene BAX and familial dilated cardiomyopathy.